{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:14:54Z","timestamp":1793420094917,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016M3A9B5942352"],"award-info":[{"award-number":["2016M3A9B5942352"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A1A13027811"],"award-info":[{"award-number":["2015R1A2A1A13027811"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biomaterials.2017.09.009","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T09:34:17Z","timestamp":1504776857000},"page":"26-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response"],"prefix":"10.1016","volume":"147","author":[{"given":"Bo-Kyeong","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eonju","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Dong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.09.009_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/17425247.2016.1158707","article-title":"Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy","volume":"13","author":"Yoon","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2015.10.009","article-title":"Polymeric oncolytic adenovirus for cancer gene therapy","volume":"219","author":"Choi","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/cgt.2012.95","article-title":"Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers","volume":"20","author":"Choi","year":"2013","journal-title":"Cancer gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/gt.2011.125","article-title":"Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF","volume":"19","author":"Choi","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/sj.gt.3302759","article-title":"Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect","volume":"13","author":"Choi","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.gt.3301858","article-title":"Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response","volume":"9","author":"Sailaja","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gt.2013.10","article-title":"Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy","volume":"20","author":"Choi","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"Kasala","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib11","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","article-title":"\u201cStealth\u201d adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung","volume":"75","author":"Croyle","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib12","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1089\/104303402760372972","article-title":"PEGylation of E1-Deleted adenovirus vectors allows significant gene expression on readministration to liver","volume":"13","author":"Croyle NC","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib13","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.biomaterials.2013.03.004","article-title":"Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/hum.2011.014","article-title":"Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models","volume":"22","author":"Wang","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2011.08.036","article-title":"Fibrin hydrogels for lentiviral gene delivery in\u00a0vitro and in\u00a0vivo","volume":"157","author":"Kidd","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","article-title":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","volume":"220","author":"Na","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib17","first-page":"6","article-title":"Engineered hydrogels for local and sustained delivery of RNA-interference therapies","author":"Wang","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2008.01.005","article-title":"In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery","volume":"127","author":"He","year":"2008","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0168-3659(03)00364-X","article-title":"In\u00a0vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel","volume":"92","author":"Konishi","year":"2003","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jconrel.2013.09.019","article-title":"Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research","volume":"172","author":"Elzoghby","year":"2013","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib22","series-title":"Biomaterials Applications for Nanomedicine","article-title":"Collagen- vs. Gelatine-Based biomaterials and their biocompatibility: review and perspectives","author":"Kokol SGaV","year":"2011"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib23","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1002\/adfm.201401110","article-title":"In situ crosslinkable gelatin hydrogels for vasculogenic induction and delivery of mesenchymal stem cells","volume":"24","author":"Lee","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib24","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.18632\/oncotarget.13972","article-title":"Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model","volume":"8","author":"Oh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib25","doi-asserted-by":"crossref","first-page":"84965","DOI":"10.18632\/oncotarget.13087","article-title":"Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy","volume":"7","author":"Ahn","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib26","doi-asserted-by":"crossref","first-page":"e67512","DOI":"10.1371\/journal.pone.0067512","article-title":"Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-gamma- and TNF-alpha-co-producing T cell-mediated antitumor immunity","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/104303403769211637","article-title":"Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner","volume":"14","author":"Kim","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib28","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","article-title":"Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors","volume":"66","author":"Thomas","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib30","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/mt.2008.162","article-title":"Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model","volume":"16","author":"Thomas","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2217\/nnm-2016-0060","article-title":"Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy","volume":"11","author":"Kasala","year":"2016","journal-title":"Nanomed. (Lond)"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2004.04.059","article-title":"Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors","volume":"22","author":"Sangro","year":"2004","journal-title":"J.\u00a0Clin. Oncol. Official J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.imbio.2005.04.002","article-title":"HSP110 induces \u201cdanger signals\u201d upon interaction with antigen presenting cells and mouse mammary carcinoma","volume":"210","author":"Manjili","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/sj.onc.1210884","article-title":"Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation","volume":"27","author":"Endo","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ymthe.2005.03.026","article-title":"HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer","volume":"12","author":"Benencia","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib36","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-12-2546","article-title":"Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus","volume":"19","author":"Kanerva","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1158\/0008-5472.CAN-11-3001","article-title":"Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients","volume":"72","author":"Pesonen","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4049\/jimmunol.179.1.391","article-title":"Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection","volume":"179","author":"Yoon","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib39","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/mt.2009.205","article-title":"Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL","volume":"18","author":"Huang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301377","article-title":"Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?","volume":"8","author":"Kirn","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr. Cancer Drug Tar."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2014.09.058","article-title":"Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations","volume":"476","author":"Chen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0167-4781(00)00306-7","article-title":"Enhanced activity of cloned hamster TERT gene promoter in transformed cells","volume":"1517","author":"Guo","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biomaterials.2017.09.009_bib45","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1158\/0008-5472.CAN-09-3567","article-title":"Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients","volume":"70","author":"Cerullo","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","article-title":"Oncolytic viruses and their application to cancer immunotherapy","volume":"2","author":"Chiocca","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1586\/14737140.8.10.1581","article-title":"Oncolytic viruses: a novel form of immunotherapy","volume":"8","author":"Prestwich","year":"2008","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1525-0016(03)00199-0","article-title":"Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy","volume":"8","author":"Hallden","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.009_bib49","series-title":"Applications of Viruses for Cancer Therapy","author":"Curiel","year":"2012"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217305720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217305720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:27:48Z","timestamp":1758904068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217305720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":49,"alternative-id":["S0142961217305720"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.009","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}